Skip to content

Subscriptions are live.

Plans

Why is $ANIP stock up today?

ANI Pharmaceuticals, Inc. · PHARMACEUTICAL PREPARATIONS

Why is $ANIP up today?

The likely driver

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
SEC filing · Aug 24
Price
$73.16
Move today
+0.8%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
48
Market cap
$1.8B
Prev close
$72.58
Avg volume
381K

Nothing has triggered on ANIP yet in this session. Our scanner has flagged it 48 times in the last 30 days , most recently on October 14 for big percentage moves, unusual volume, which is why this page is here. See the full ANIP page for the chart and the alert history.

Earlier scanner activity on ANIP

  • Oct 14Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 12Unusual volume (RVOL) alert
  • Oct 12Unusual volume (RVOL) alert
  • Oct 12Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $ANIP alerts the moment volume spikes

Our scanner flagged $ANIP 48 times in the last 30 days. Create a free account to track $ANIP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.